Qualitative confirmation procedure for ephedrines as acetonide derivatives in doping urine samples by gas chromatography/electron ionization mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 23, Issue 2, 2009, Pages 249-257

  De Oca Porto, Rodny Montes ^a   Pérez, Arístides Rosado ^a   Vidal, Margarita Teresa Correa ^a   Fraga, Mario Granda ^a  

^a Laboratorio Antidoping   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; AMINES; BODY FLUIDS; DRUG PRODUCTS; IONIZATION OF GASES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CENTRAL NERVOUS SYSTEMS; ELECTRON IONIZATION; ELECTRON IONIZATION MASS SPECTROMETRY; GASCHROMATOGRAPHY-MASS SPECTROMETRY; HUMAN URINE; PROPERTY; PSEUDOEPHEDRINE; SIMPLE++; URINE SAMPLE; WORLD ANTI-DOPING AGENCY;

GAS CHROMATOGRAPHY;

EID: 60149099702     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3872     Document Type: Article

References (23)

1. Gmeiner G, Geinsendorfer T, Kainzbauer J, Nikolajevic M. Recent Advances in Doping Analysis, vol. 9, Donike M, Schänzer W, Gotzmann A, Mareck-Engelke U (eds). Sport and Buch Strauss: Köln, Germany, 2001; 43.
2. WADA. The World Antidoping Code. International Standard for the Prohibited List. The 2008 Prohibited List. Available: http://www.wada-ama.org/ rtcontent/document/2008-List-En.pdf (accessed 29.09.2008).
3. Kunsman GW. J. Anal. Toxicol. 1998; 10: 310.
4. Hansen LB. J. Pharm. Sci. 2001; 90: 943.
5. Fillmore CM, Bartoli L, Bach R, Park Y. Phys. Med. Rehab. Clin. N. Am. 1999; 10: 673.
6. Marchei E, Pellegrini M, Pacifi R, Zuccaro P, Pichini S. J. Pharm. Biomed. Anal. 2006; 41: 1633.
7. Bruno A, Nolte K, Chapin J. Neurology 1993; 43: 1313.
8. Nadeau S. Ann. Neurol. 1984; 15: 114.
9. Muller S. N. Engl. J. Med. 1983; 308: 653.
10. Cornelius J, Soloff P, Reynolds C. Am. J. Psychiatr. 1984; 141: 120.
11. Rents S. Sports and Exercise Pharmacology. Human Kinetics: Champaign, IL, 2000; 105-115.
12. Sidney KH, Lefcoe WM. Med. Sci. Sports 1977; 9: 95.
13. Rawson ES, Clarkson PM. Ephedrine as an ergogenic aid, In Performance-Enhancing Substances in Sport and Exercise, Barhke MS, Yesalis CE (eds). Human Kinetics: Champaign, IL, 2002; 289-298.
14. Van Eenoo P, Delbeke F, Roels K, De Backer P. J. Chromatogr. B 2001; 760: 255.
15. Thevis M, Sigmund G, Schänzer W. Recent Advances in Doping Analysis, vol 11, Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds). Sport and Buch Strauss: Köln, Germany, 2003; 303.
16. Spyridaki M, Tsitsimpikou C, Siskos CJ, Geokargopoulos CG. J. Chromatogr. B 2001; 758: 311.
17. Hemmersbach P, de la Torre R. J. Chromatogr. B 1996; 687: 221.
18. Saito T, Mase H, Takeichi S, Inokuchi S. J. Pharm Biomed. Anal. 2007; 43: 358.
19. Tseng YL, Shieh M, Kuo F. Forensic Sci. Int. 2006; 157: 149.
20. Forsdalh G, Gmeiner G. J. Chromatogr. B 2001; 758: 311.
21. Georgeta B, Graziela V, Mia L, Valentin P, Barbu C. Recent Advances in Doping Analysis, vol 12, Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds). Sport and Buch Strauss: Köln, Germany, 2004; 359.
22. WADA. TD2003IDCR, Identification criteria for qualitative assays incorporating chromatography and mass spectrometry. WADA Technical Document 2003, version 1.2. Available: http://www.wada-ama.org/rtcontent/document/ criteria-1-2.pdf (accessed 29.09.2008).
23. Zaikin VG, Halket JM. Eur. J. Mass Spectrom. 2004; 10: 555.